Covid, hawkish policy stance is unwinding, and history suggests that this phase of the cycle tends to reward investors who move early rather than wait for consensus comfort.

Celldex Therapeutics CLDX saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from ...

The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were ...

As of Wednesday, December 31, Sable Offshore Corp.’s SOC share price has dipped by 8.11%, which has investors questioning if ...

As of Wednesday, December 31, Corcept Therapeutics Incorporated’s CORT share price has dipped by 47.02%, which has investors ...

iShares MSCI Germany ETF (EWG) remains a hold, with valuation attractive but technicals and seasonality neutral. EWG's 2025 ...

A host of global and domestic brokerages have released fresh views on ITC, Devyani International Limited, Dr Reddy's ...

The domestic real estate investment trust (M-REITs) market is expected to be subdued as uncertainty over the withholding tax ...

Heading into any period of uncertainty (which I’d argue can basically account for any period in the future investors have ...

As stablecoins become an increasingly prominent feature of the financial landscape, Noelle Acheson gives us her top five ...

IPO funds used mainly for promoter exits, not assets—see Sanjeev Prasad’s 2026 outlook and market drivers. Read key insights ...

Experts have recommended eight stocks to buy today — Indus Towers, JK Tyre & Industries, CG Power and Industrial Solutions, ...